Clinical Trials List
2009-02-01 - 2013-02-01
Phase III
Terminated7
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳盈憲 Division of Cardiovascular Diseases
- MAO-HSIN LIN Division of Cardiovascular Diseases
- Hsien Li Kao Division of Cardiovascular Diseases
- 何奕倫 Division of Cardiovascular Diseases
- Tzung-Dau Wang Division of Cardiovascular Diseases
- YEN-HUNG LIN Division of Cardiovascular Diseases
- 黃惠君 醫師 Division of Cardiovascular Diseases
- 趙嘉倫 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
350 participants
-
Global
15,500 participants
